Feed MSB.AX
MS
Mesoblast Limited
MSB.AX · ASX
$2.22 -0.45% (-$0.01)
1M +6.19%
Market Cap $2.0B
P/E Ratio -
Div. Yield -
ROE 19.51%
Valuation
30 /100
Expensive P/B 3.40x
P/S 118.27x
P/FFO N/A
Growth
91 /100
Growing Book val. growth 6.32%
Rev. growth 18.98%
FCF growth N/A
Profitability
20 /100
Weak Net margin 593.92%
Op. margin 363.08%
FCF margin 294.71%
Quality
0 /100
Poor ROE 19.51%
ROA 13.02%
Asset turnover 0.02x
Debt
69 /100
Low Current ratio 1.99x
Int. coverage -3.68x
Debt/Equity 0.21x
Stability
56 /100
Moderate Rev. volatility 124.34%
EPS volatility 11.93%
Profitable years 0
Întreabă StockBot despre MSB.AX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Silviu Itescu
Employees
81
Headquarters
Melbourne
Evenimente viitoare
02 SEPT.
Earnings
Upcoming earnings report